ctdna as a biomarker for post-resection colorectal cancer recurrence
Published 6 months ago • 150 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:39
the future of ctdna as an indicator of colorectal cancer recurrence at esmo 2023
-
1:02
galaxy: ctdna as a prognostic biomarker in resected colorectal cancer
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
3:16
the utility of ctdna in colorectal cancer management
-
30:04
allycon 2021: how ctdna is used in colorectal cancer recurrence monitoring
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
3:29
ctdna and cfdna : prognostic value in the neoadjuvant setting of colon cancer
-
6:22
utilising ctdna in oncology
-
0:44
using ctdna to identify mutations in colorectal cancer
-
6:58
personalizing ctdna analysis to predict crc relapse
-
25:08
is my treatment working? using ctdna to optimize the management of colorectal cancer
-
0:45
the emerging role of ctdna in cancer diagnostics
-
1:57
ctdna, a biomarker of residual disease and tumor response in gastrointestinal cancers
-
7:53
ctdna mrd detection from plasma and urine in colorectal cancer
-
2:01
pre-treatment ctdna linked to increased risk of early recurrence in io-treated melanoma
-
4:26
fundamentals of ctdna
-
1:22
dr. overman on potential applications of ctdna in colorectal cancer
-
7:32
part 4 -ctdna as a potential prognostic marker for locally advanced rectal cancer patients-dr ritika
-
3:18
conversion from unresectable to resectable mcrc in real-world patients